RNXT RenovoRx

Watchlist

1.040
+0.010+0.97%

Close Feb 14 16:00 ET

1.060
+0.020+1.92%

Post 20:01 ET

36.99MMarket Cap-1.79P/E (TTM)

About RenovoRx Company

RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Mountain View, CA.

Company Profile

SymbolRNXT

Company NameRenovoRx

Listing DateAug 26, 2021

Issue Price9.00

Founded2012

CEOMr. Shaun R. Bagai

MarketNASDAQ

Employees8

Fiscal Year Ends12-31

Address2570 West El Camino Real,Suite 320

CityMountain View

ProvinceCalifornia

CountryUnited States of America

Zip Code94040

Phone1-650-284-4433

Websitehttp://www.renovorx.com

Company Executives

Name
Position
Salary

Shaun R. Bagai
Chief Executive Officer and Director
939.12K

Dr. Ramtin Agah, M.D.
Chief Medical Officer and Chairman of the Board
507.76K

Leesa Gentry
Chief Clinical Officer
--

Ronald B. Kocak
Vice President, Controller and Principal Accounting Officer
--

Dr. Robert J. Spiegel, F.A.C.P.,M.D.
Independent Director
173.72K

Dr. Una S. Ryan,PhD
Independent Director
82.00K

Kirsten Angela Macfarlane
Independent Director
82.00K

Dr. Laurence J. Marton, M.D.
Independent Director
77.00K

RNXT RenovoRx

About RenovoRx Company

Company Profile

Company Executives

Trending Stocks